Health Highlights: Oct. 4, 2021
New, better antivirals against COVID-19 are on the way. On Friday, drug giant Merck announced it would seek FDA emergency use approval for a powerful new antiviral, molnupiravir. At least two more such drugs that target the SARS-CoV-2 virus are in the pipeline from other companies, and could save thousandsContinue Reading